ISBN:
9780323681353
Copyright:
2023
Publication Date:
03-07-2022
Page Count:
544
Imprint:
Elsevier
List Price:
$132.99
Cardio-Oncology Practice Manual: A Companion to Braunwald’s Heart Disease, 1st Edition
by Joerg Herrmann, MD
Paperback
ISBN:
9780323681353
Copyright:
2023
Publication Date:
03-07-2022
Page Count:
544
Imprint:
Elsevier
List Price:
$132.99
-
- Covers all major cancer therapies, cardiovascular toxicities, and malignancies in a portable, authoritative guide—ideal for cardiologists, cardio-oncologists, general practitioners, internists, medical oncologists, and hematologists.
- Offers templated and streamlined content for quick retrieval, with key point summaries for each major section.
- Presents cardiac disease entities and specific malignant diseases in a succinct overview format addressing important clinical care aspects.
- Features "Central Illustrations" for each topic that visually summarize the chapter and its specific content including algorithms for management of cardiovascular toxicities and one-view overviews of malignancies.
- Includes a comprehensive drug guide that provides quick reference to drugs prescribed for cancers with therapeutic indications, manifestations and mechanisms of cardiotoxicity, their risk factors, and risk reduction strategies.
- Brings you up to date with new immune therapies, including immune checkpoint inhibitors and CAR T-cell therapies
- Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
-
1 The Cardio-Oncology Clinic: Goals, Scope, and Focus of Practice
2 Key Points of Cardio-Oncology Evaluation Before Cancer Therapy
3 Cardiovascular Risks of Chemotherapy
4 Radiation Therapy Cardiovascular Risks
5 Bone Marrow Transplantation Risk
6 Surgical Risks
7 Prevention of Heart Failure and Cardiomyopathy in Patients With Cancer
8 Vascular Disease Prevention: Before Cancer Therapy
9 Thromboembolic Disease Prevention: Before Cancer Therapy
10 Arrhythmia Prevention and Device Management: Before Cancer Therapy
11 Hypertension and Renal Disease Prevention: Before Cancer Therapy
12 Prevention and Management of Pulmonary Conditions in Cancer Patients Before Therapy
13 Cardiopulmonary Exercise for Prevention: Before Cancer Therapy
14 Key Points of Cardio-Oncology Evaluation During Cancer Therapy
15 Diagnosis and Management of Cardiomyopathy and Heart Failure During Cancer Treatment
16 Structural Heart Disease Mangement During Cancer Treatment
17 Vascular Disease During Cancer Therapy
18 Thromboembolic Disease During Cancer Therapy
19 Arrhythmia and Device Assessment During Cancer Treatments
20 Hypertension and Renal Disease During Anti-Cancer Therapies
21 Pulmonary Disease During Cancer Therapy
22 Cardiovascular Testing In The Cancer Patient
23 Key Points of Cardio-Oncology Evaluation After Cancer Therapy
24 Cancer Survivorship and Comorbidity Disease Risk After Cancer Treatment
25 Long-Term Complications of Chemotherapy
26 Long-Term Complications of Radiation Therapy
27 Cardiopulmonary Rehabilitation
27 Prevention and Management of Heart Disease in Cancer Survivors
28 Structural Heart Disease Prevention and Management in Cancer Survivors
29 Vascular Disease Prevention and Management After Cancer Therapy
30 Prevention of VTE After Initial Presentation and Cancer Treatment
31 Arrhythmia Prevention and Management in Cancer Survivors
32 Hypertension and Renal Failure Prevention and Management After Cancer Therapy
33 Monitoring for and Management of Delayed Complications After Cancer Therapy
34 Cardiopulmonary Rehabilitation for Cancer Patients and Survivors
35 Breast Cancer
36 Gynecologic Malignancies
37 Prostate and Testicular Cancer
38 Renal and Urinary Bladder Cancer
39 Lung Cancer
40 Colorectal Cancer
41 Esophageal and Gastric Cancer
42 Hepatobiliary Carcinomas
43 Pancreatic Cancer
44 Cutaneous Melanoma
45 Head-and-Neck Cancers
46 Thyroid cancer
47 Glioblastoma
48 Introduction to the Management of Soft Tissue Sarcomas
49 Acute and Chronic Leukemias
50 Lymphomas
51 Multiple Myeloma and Cardiac Amyloidosis
52 Carcinoid Tumors and Carcinoid Heart Disease
53 Neoplasms and The Heart
54 Cancer Therapeutic Drug Guide
as described in our 